Search details
1.
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Cell
; 167(1): 260-274.e22, 2016 09 22.
Article
in English
| MEDLINE | ID: mdl-27641504
2.
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay Performance.
Mod Pathol
; 37(4): 100445, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38341130
3.
Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature
; 554(7693): 554, 2018 02 22.
Article
in English
| MEDLINE | ID: mdl-29342137
4.
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecol Oncol
; 171: 106-113, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36868112
5.
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Nature
; 547(7661): 109-113, 2017 07 06.
Article
in English
| MEDLINE | ID: mdl-28658205
6.
SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.
Br J Cancer
; 124(5): 951-962, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33339894
7.
PI3K activation promotes resistance to eribulin in HER2-negative breast cancer.
Br J Cancer
; 124(9): 1581-1591, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33723394
8.
Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.
Proc Natl Acad Sci U S A
; 115(11): E2594-E2603, 2018 03 13.
Article
in English
| MEDLINE | ID: mdl-29476008
9.
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
Breast Cancer Res
; 22(1): 120, 2020 11 02.
Article
in English
| MEDLINE | ID: mdl-33138866
10.
Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity.
PLoS Genet
; 12(9): e1006279, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27588951
11.
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Gynecol Oncol
; 175: 194, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37271667
12.
Targeting a cell state common to triple-negative breast cancers.
Mol Syst Biol
; 11(1): 789, 2015 Feb 19.
Article
in English
| MEDLINE | ID: mdl-25699542
13.
Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN.
Methods
; 77-78: 25-30, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25697760
14.
Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients.
Proc Natl Acad Sci U S A
; 108(9): 3761-6, 2011 Mar 01.
Article
in English
| MEDLINE | ID: mdl-21321214
15.
Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.
JCO Precis Oncol
; 8: e2300446, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38513169
16.
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
JAMA Netw Open
; 7(4): e247811, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38648056
17.
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models.
Sci Rep
; 13(1): 2710, 2023 02 15.
Article
in English
| MEDLINE | ID: mdl-36792625
18.
RAD51 as a biomarker for homologous recombination deficiency in high-grade serous ovarian carcinoma: robustness and interobserver variability of the RAD51 test.
J Pathol Clin Res
; 9(6): 442-448, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37504067
19.
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
EMBO Mol Med
; 15(1): e16033, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36426578
20.
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer.
Clin Cancer Res
; 29(13): 2466-2479, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37097615